Sat, Jul 26, 2014, 4:19 AM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Celldex Therapeutics, Inc. Message Board

  • weightbayou weightbayou Jul 4, 2013 8:22 PM Flag

    Celldex has 2 potential drugs for blood cancers.

    Management at Celgene could be in panic mode.

    DEC-205/NY-ESO-1 Fusion Protein CDX-1401and Decitabine in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
    This study is not yet open for participant recruitment.
    Verified June 2013 by Roswell Park Cancer Institute
    Sponsor:
    Roswell Park Cancer Institute
    Collaborator:
    National Cancer Institute (NCI)
    Information provided by (Responsible Party):
    Roswell Park Cancer Institute

    A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers
    This study is currently recruiting participants.
    Verified May 2013 by Celldex Therapeutics
    Sponsor:
    Celldex Therapeutics
    Information provided by (Responsible Party):
    Celldex TherapeuticsClinicalTrials.gov Identifier:
    NCT01460134
    First received: October 12, 2011
    Last updated: May 23, 2013
    Last verified: May 2013
    History of Changes

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
CLDX
13.57-0.50(-3.55%)Jul 25 3:59 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.